Tue. January 06, 2009
-
guardian.co.uk
December 10, 2008
BRUSSELS, Dec 10 (Reuters) - Belgian
Biotechnology company
Galapagos may sell its service division BioFocus DPI in 2010 if the price is right and if the ...
Reuters UK
December 9, 2008
Live-PR.com (Pressemitteilung)
November 27, 2008
In the same month US ophthalmic firm Bausch & Lomb (B&L) announced a strategic research collaboration with Belgian drug discovery company
Galapagos NV. ...
Reuters
November 26, 2008
BRUSSELS, Nov 26 (Reuters) - Belgian
Biotechnology company
Galapagos (GLPG.BR: Quote, Profile, Research, Stock Buzz) said on Wednesday it would partner with ...
Ninemsn
November 4, 2008
BRUSSELS, Nov 5 (Reuters) - Belgian
Biotechnology company
Galapagos said on Wednesday it had completed the sale of its BioFocus DPI
chemistry facility in ...
PR-Inside.com (Pressemitteilung)
October 29, 2008
In the same month US ophthalmic firm Bausch & Lomb (B&L) announced a strategic research collaboration with Belgian drug discovery company
Galapagos NV. ...
PR-Inside.com (Pressemitteilung)
October 16, 2008
In the same month US ophthalmic firm Bausch & Lomb (B&L) announced a strategic research collaboration with Belgian drug discovery company
Galapagos NV. ...
PharmaLive.com (press release)
October 6, 2008
In the same month US ophthalmic firm Bausch & Lomb (B&L) announced a strategic research collaboration with Belgian drug discovery company
Galapagos NV. ...
MarketWatch
October 6, 2008
In the same month US ophthalmic firm Bausch & Lomb (B&L) announced a strategic research collaboration with Belgian drug discovery company
Galapagos NV. ...
WCAX
August 22, 2008
The company founder shoots much of the video himself on location. "I've been to the Canadian Rockies, the
Galapagos islands, the Grand Canyon, ...
ShareCast
August 21, 2008
... due largely to an impairment charge of £2.2m related to the reduction in value of the company's shareholding in drug discovery company
Galapagos NV. ...
Scotsman
August 10, 2008
By Hamish Rutherford PROSTRAKAN is believed to have raised about 5 million (£3.9m) by selling its stake in Belgian drug development company
Galapagos. ...
Le Scienze Web News
July 23, 2008
... on the properties and activities of drugs and a large set of drug-like small
molecules from publicly listed company
Galapagos NV to the public domain. ...
Forbes
May 29, 2008
(BioFocus is a unit of Belgian drug discovery company
Galapagos.) BioFocus will develop a test to screen the motor neurons against some 11000 different ...
Business Weekly
May 22, 2008
parent company,
Galapagos NV, has signed a $1.8 million (£0.92m) drug discovery research agreement with University College
London to be handled by BioFocus ...
Bloomberg
May 20, 2008
... Belgian drug discovery company
Galapagos NV, said Chris Airriess, the
California company's chief operating officer, in a telephone interview yesterday. ...
Interactive Investor
May 6, 2008
BRUSSELS (Thomson Financial) - Drug discovery company
Galapagos NV. said its service division BioFocus DPI has signed an agreement with Allergan Inc. to ...
Bio-IT World
March 20, 2008
The new license also extends BioFocus DPI's coverage to include its
parent company,
Galapagos. BioFocus DPI and Galapagos will now have the facility to ...
RTT News
March 7, 2008
3/7/2008 4:51:00 AM Drug discovery company
Galapagos NV (GLPG.L) on Friday reported wider net loss in its fiscal year 2007, reflecting higher operating ...
Reuters
March 6, 2008
BRUSSELS, March 7 (Reuters) - Belgian
Biotechnology company
Galapagos (GLPG.BR: Quote, Profile, Research)(GLPG.AS: Quote, Profile, Research) reported an 87 ...
Reuters
February 26, 2008
BRUSSELS, Feb 27 (Reuters) - Belgian
Biotechnology company
Galapagos (GLPG.BR: Quote, Profile, Research) (GLPG.AS: Quote, Profile, Research) said on ...
New Europe
January 19, 2008
Mechelen-based drug discovery company,
Galapagos's service division BioFocus DPI has extended its drug discovery agreement with
Eli Lilly and Company until ...
CNNMoney.com
January 17, 2008
Biotech company
Galapagos fell less than the
market after said it has been awarded a 4.4 mln eur grant from the Flanders government for rheumatoid arthritis ...
Forbes
January 16, 2008
London (Thomson Financial) - Belgian drug discovery company
Galapagos NV said it has been awarded a 4.4 mln eur grant from the Flanders government for ...
Genetic Engineering News (press release)
January 3, 2008
The two-year target discovery collaboration will use an adenoviral platform from
parent company,
Galapagos, to identify novel drug targets. ...
Reuters
January 2, 2008
BRUSSELS, Jan 3 (Reuters) - Belgian
Biotechnology company
Galapagos (GLPG.BR: Quote, Profile, Research)(GLPG.AS: Quote, Profile, Research) said on Thursday ...
Reuters
December 18, 2007
BRUSSELS, Dec 19 (Reuters) - Belgian
Biotechnology company
Galapagos (GLPG.BR: Quote, Profile, Research)(GLPG.AS: Quote, Profile, Research) said on ...
Hemscott
December 18, 2007
Paris (Thomson Financial) - Belgian drug discovery company
Galapagos said it has reached significant milestones in its multi-year drug discovery alliance ...
Hemscott
December 18, 2007
London (Thomson Financial) - Belgian drug discovery company
Galapagos announced a collaboration agreement with
Eli Lilly and Co to develop potential new ...
nebusiness.co.uk
December 11, 2007
In addition,
GlaxoSmithKline has formed a "multi-year strategic alliance" with
Galapagos, the Belgian pharmaceutical company. Galapagos will receive up to ...
RTT News
December 10, 2007
... that it has entered into a strategic alliance with
Belgium-based drug discovery company,
Galapagos NV to develop new antibacterials and antivirals. ...
Hemscott
December 10, 2007
London (Thomson Financial) - Belgian pharmaceuticals company
Galapagos said it has agreed a multi-year strategic alliance with
GlaxoSmithKline for the ...
ABCmoney.co.uk
November 29, 2007
By : Agencies
London (Thomson Financial) - Belgian
biotechnology company
Galapagos and Cystic Fibrosis Foundation Therapeutics (CFFT) announced a new drug ...
Reuters
November 28, 2007
BRUSSELS, Nov 29 (Reuters) - Belgian
Biotechnology company
Galapagos (GLPG.BR: Quote, Profile, Research)(GLPG.AS: Quote, Profile, Research) said on Thursday ...
Playbill.com
November 11, 2007
... Epic Theatre Center, Faux-Real Theatre Company,
Galapagos Art Space, Gansfield Theatre Company, Guerrilla Girls on Tour, HERE
arts Center, Hoi Polloi, ...
Playbill.com
November 2, 2007
... Epic Theatre Center, Faux-Real Theatre Company,
Galapagos Art Space, Gansfield Theatre Company, Guerrilla Girls on Tour, HERE
arts Center, Hoi Polloi, ...
